Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer

Yi Li1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Cheng Liu2 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;4 Center for Biomedical Imaging, Fudan University, Shanghai, People’s Republic of China;5 Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, People’s Republic of China;6 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of ChinaView further author information

Bibo Wang7 Orthopaedic Department, Shanghai Ruijin Hospital, Shanghai Jiaotong University Medicine School, Shanghai, People’s Republic of ChinaView further author information

Xichun Hu1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Chengcheng Gong1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yannan Zhao1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yizhao Xie1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Yingjian Zhang2 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;4 Center for Biomedical Imaging, Fudan University, Shanghai, People’s Republic of China;5 Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, People’s Republic of China;6 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of ChinaView further author information

Shaoli Song2 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;4 Center for Biomedical Imaging, Fudan University, Shanghai, People’s Republic of China;5 Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, People’s Republic of China;6 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of ChinaView further author information

Zhongyi Yang2 Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;4 Center for Biomedical Imaging, Fudan University, Shanghai, People’s Republic of China;5 Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, People’s Republic of China;6 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Biyun Wang1 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date